Latest Healthtech Startup Funding Rounds
Companies building technology for healthcare delivery, diagnosis, clinical workflows and patient access.
- Rounds
- 744 Jan 1 – Oct 24, 2026
- Disclosed funding
- $25.3B 606 disclosed amounts
- Median round
- $16M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| CH Automates the financial infrastructure of American healthcare | $120M | Series DSeries C+ | Healthtech | United States | Investors | |
| P PawPay turns any policy into pet insurance that pays vet directly | Undisclosed | Undisclosed | Healthtech, Fintech | United States | Investors | |
| CT Crystalys TherapeuticsCompany profile Crystalys Therapeutics develops dotinurad, an oral URAT1 inhibitor for treating gout Crystalys Therapeutics develops dotinurad, an oral URAT1 inhibitor for treating gout | $130M | Series B | Healthtech, Biotech | United States | Investors | |
| NB N-Zyme BiomedicalCompany profile Developing first-in-class therapies targeting pepsin for reflux disease Developing first-in-class therapies targeting pepsin for reflux disease | $4.6M | Series A | Healthtech, Biotech | United States | Investors Undisclosed | |
| HE Health EndeavorsCompany profile Health Endeavors provides AI-driven care management tools for accountable care organizations Health Endeavors provides AI-driven care management tools for accountable care organizations | Undisclosed | Growth | Healthtech | United States | Investors | |
| IL Inner LogicCompany profile Simulates how procedural devices perform across virtual patients before clinical deployment Simulates how procedural devices perform across virtual patients before clinical deployment | $11.5M | Seed | Healthtech | United States | Investors | |
| RN Rege Nephro CoCompany profile Developing innovative therapies and medical technologies for patients with kidney diseases who currently have limited treatment options Developing innovative therapies and medical technologies for patients with kidney diseases who currently have limited treatment options | $10.6M | Series CSeries C+ | Healthtech, Biotech | Japan | Investors | |
| TH TYBR HealthCompany profile TYBR Health builds technology for the critical healing window after surgery TYBR Health builds technology for the critical healing window after surgery | $30M | Series A | Healthtech | United States | Investors | |
| KH Karoo HealthCompany profile Building an operating system connecting payers, providers, and patients for cardiovascular care Building an operating system connecting payers, providers, and patients for cardiovascular care | $16.2M | Series A | Healthtech | United States | Investors | |
| BH Bunkerhill HealthCompany profile Bunkerhill Health builds an agentic AI platform for health systems to turn their ideas into reality Bunkerhill Health builds an agentic AI platform for health systems to turn their ideas into reality | $25M | Series B | Healthtech | United States | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · From Jan 1, 2026
- 1General Catalyst
Baba, Disha (formerly Curelink), Thatch
23rounds2led - 2Y Combinator (YC)
Vitalize, Angle Health, Metriport
21rounds0led - 3Alumni Ventures
MintNeuro, Evvy, Hopscotch Primary Care
13rounds0led - 4Andreessen Horowitz (a16z)
Sharp Performance, General Medicine, Devoted Health
12rounds2led - 5Khosla Ventures
Even Healthcare, Abby Care, Rightway
11rounds1led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.